Dorian P. LeBlanc serves as Executive Vice President and Chief Financial Officer of LeMaitre Vascular, Inc., a leading global provider of medical devices and implants for vascular surgery. In this pivotal role since joining the company in 2015, he oversees all aspects of financial strategy, including budgeting, forecasting, treasury management, investor relations, and regulatory compliance. LeBlanc's leadership has been instrumental in driving LeMaitre's financial discipline and supporting its expansion through strategic acquisitions and organic growth in international markets. Prior to LeMaitre, LeBlanc held the position of Chief Financial Officer at Endologix, Inc. from 2012 to 2015, where he managed financial operations during a phase of rapid innovation and clinical trial advancements in endovascular aneurysm repair. His earlier career included senior finance roles at MAQUET Cardiovascular LLC, focusing on mergers and acquisitions, and at Boston Scientific Corporation, where he gained deep expertise in global financial reporting and operational efficiency. A Certified Public Accountant, LeBlanc earned an MBA from Harvard Business School and a BS in Accountancy from Bentley University. Under LeBlanc's stewardship, LeMaitre Vascular has delivered consistent revenue growth exceeding 10% annually in recent years, bolstered by key acquisitions such as Artegraft and the ChemoFilter business, while maintaining strong profitability and shareholder returns. His strategic acumen has positioned the company as a resilient leader in the vascular device sector, navigating market challenges with prudent capital allocation and robust cash flow management.